U.S. Markets closed

AstraZeneca PLC (AZN.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
5,152.00+29.00 (+0.57%)
At close: 4:35PM BST
Full screen
Previous Close5,123.00
Open5,135.00
Bid5,050.00 x 6100
Ask5,290.00 x 13000
Day's Range5,120.00 - 5,172.00
52 Week Range3,996.00 - 5,520.00
Volume1,577,047
Avg. Volume1,964,627
Market Cap65.21B
Beta0.67
PE Ratio (TTM)19.30
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.80 (4.19%)
Ex-Dividend Date2017-02-16
1y Target EstN/A
  • Biotechs On A Hot Streak, And Could Be 'Cooking With Gas'
    Investor's Business Daily8 hours ago

    Biotechs On A Hot Streak, And Could Be 'Cooking With Gas'

    IBD's 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?

  • Reuters15 hours ago

    GlaxoSmithKline's new CEO prepares to trim drug pipeline

    GlaxoSmithKline's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focusing the company's pipeline of new drugs. Despite her non-pharmaceutical background in consumer brands, Emma Walmsley sees improving drug research productivity as her top priority, and she wants Britain's biggest drugmaker to have fewer but potentially more lucrative new medicine launches in future.

  • Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod
    Zacks16 hours ago

    Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod

    Pharma sector second quarter earnings season has started with industry bellwether Johnson & Johnson (JNJ) reporting earlier this week while AstraZeneca and Merck provided regulatory updates.